In this study, we found that the combined BJIGT/RZ treatment attenuated the expression of the muscle denervation markers, Chrng and Myog, compared with that in the control group in ALS mice (Figure 4B). This evidence concerns the gene CHRNG and amyotrophic lateral sclerosis.